Tirzepatide
Dual GIP/GLP-1 receptor agonist evaluated for weight and cardiometabolic health.
Starting at$229/month
Baseline Labs Generally Required
Provider-directed options addressing appetite regulation, metabolic support, and sustainable weight change.
Dual GIP/GLP-1 receptor agonist evaluated for weight and cardiometabolic health.
A GLP-1 receptor agonist commonly evaluated for medical weight management and metabolic support.
Modified GH fragment studied for lipolysis in research settings.
GHRH analog with FDA approval for a specific HIV-related indication; sometimes discussed off-label.
Coenzyme central to cellular energy, sirtuin activation, and DNA-repair pathways.
Mitochondrial-derived peptide studied in metabolic homeostasis research.